Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
Dow Jones Industrial Average
) is trading down 9.0 points at 13,012 as of Friday, Nov 30, 2012, 1:35 p.m. ET. During this time, 294.9 million shares of the 30 Dow components have changed hands vs. an average daily trading volume of 628.5 million. The NYSE advances/declines ratio sits at 1,297 issues advancing vs. 1,627 declining with 134 unchanged.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
The Dow component leading the way higher looks to be
), which is sporting a nine-cent gain (+0.2%) bringing the stock to $54.45. Volume for UnitedHealth Group currently sits at 3.8 million shares traded vs. an average daily trading volume of 6.1 million shares.
UnitedHealth Group has a market cap of $53.88 billion and is part of the health care sector and health services industry. Shares are up 4.1% year to date as of Thursday's close. The stock's dividend yield sits at 1.6%.
UnitedHealth Group Incorporated operates as a diversified health and well-being company in the United States. The company has a P/E ratio of 10, below the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates UnitedHealth Group as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, increase in net income, revenue growth and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow.
- You can view the full UnitedHealth Group Ratings Report.
Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade